NUVOLONE, MARIO ULISSE
 Distribuzione geografica
Continente #
EU - Europa 67
NA - Nord America 5
Totale 72
Nazione #
IT - Italia 65
US - Stati Uniti d'America 5
CZ - Repubblica Ceca 2
Totale 72
Città #
Pavia 60
Milan 4
Council Bluffs 2
Brooklyn 1
Totale 67
Nome #
SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells, file e1f104fb-4c24-8c6e-e053-1005fe0aa0dd 5
Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion science, file e1f104fb-50ca-8c6e-e053-1005fe0aa0dd 5
Prion protein and Ab-related synaptic toxicity impairment, file e1f104fb-5637-8c6e-e053-1005fe0aa0dd 4
Cystatin F is a biomarker of prion pathogenesis in mice, file e1f104fb-4bb5-8c6e-e053-1005fe0aa0dd 3
Prion pathogenesis in the absence of NLRP3/ASC inflammasomes, file e1f104fb-4e84-8c6e-e053-1005fe0aa0dd 3
The immunobiology of prion diseases, file e1f104fb-4e86-8c6e-e053-1005fe0aa0dd 3
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients, file e1f104fc-7ec7-8c6e-e053-1005fe0aa0dd 3
ATR-FTIR spectroscopy supported by multivariate analysis for the characterization of adipose tissue aspirates from patients affected by systemic amyloidosis, file e1f104fc-7fd9-8c6e-e053-1005fe0aa0dd 3
Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses, file c0121e21-821e-46b9-95b7-78e224fb2b1c 2
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients, file e1f104fa-7da7-8c6e-e053-1005fe0aa0dd 2
Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture, file e1f104fb-4b29-8c6e-e053-1005fe0aa0dd 2
The Priority position paper: Protecting Europe's food chain from prions, file e1f104fb-4bac-8c6e-e053-1005fe0aa0dd 2
Structure-based drug design identifies polythiophenes as antiprion compounds, file e1f104fb-4bae-8c6e-e053-1005fe0aa0dd 2
The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis, file e1f104fb-4bb2-8c6e-e053-1005fe0aa0dd 2
Cells and prions: A license to replicate, file e1f104fb-4c26-8c6e-e053-1005fe0aa0dd 2
Altered monoaminergic systems and depressive-like behavior in congenic prion protein knock-out mice, file e1f104fb-504d-8c6e-e053-1005fe0aa0dd 2
Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients, file e1f104fb-54c6-8c6e-e053-1005fe0aa0dd 2
Extended characterization of the novel co-isogenic C57BL/6J Prnp−/− mouse line, file e1f104fb-55b5-8c6e-e053-1005fe0aa0dd 2
Efficient amyloid A clearance in the absence of immunoglobulins and complement factors, file e1f104fb-562f-8c6e-e053-1005fe0aa0dd 2
The complex PrPc-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease, file e1f104fb-5631-8c6e-e053-1005fe0aa0dd 2
Expanding the spectrum of systemic amyloid diseases: a new hint from the kidney, file e1f104fb-5632-8c6e-e053-1005fe0aa0dd 2
Systemic amyloidosis: novel therapies and role of biomarkers, file e1f104fb-5635-8c6e-e053-1005fe0aa0dd 2
Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis, file e1f104fb-ccdd-8c6e-e053-1005fe0aa0dd 2
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: Prospective study in 206 patients, file e1f104fc-7b68-8c6e-e053-1005fe0aa0dd 2
Genome-wide transcriptomics identifies an early preclinical signature of prion infection, file e1f104fc-c597-8c6e-e053-1005fe0aa0dd 2
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis, file 0fcd7bd1-84b2-424f-9bbd-727ab544caae 1
Scaling analysis reveals the mechanism and rates of prion replication in vivo, file 3623d2fd-b3f2-4749-b0e7-efa594124e18 1
Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies, file 57a27880-1fd4-4cc6-a91c-777064fa75b2 1
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis, file c616f785-2ccf-480f-9cb7-fbec0189c430 1
Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach, file e1f104fa-7724-8c6e-e053-1005fe0aa0dd 1
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis, file e1f104fa-80a7-8c6e-e053-1005fe0aa0dd 1
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis, file e1f104fb-598a-8c6e-e053-1005fe0aa0dd 1
Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling, file e1f104fb-5a10-8c6e-e053-1005fe0aa0dd 1
Bone marrow amyloidosis., file e1f104fb-5b3a-8c6e-e053-1005fe0aa0dd 1
Totale 72
Categoria #
all - tutte 271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 0 3
2022/202327 0 0 0 0 3 6 11 5 1 1 0 0
Totale 72